Biomarkers for prostate cancer detection and risk stratification

Although prostate cancer (PCa) is the most commonly diagnosed cancer in men, most patients do not die from the disease. Prostate specific antigen (PSA), the most widely used oncologic biomarker, has revolutionized screening and early detection, resulting in reduced proportion of patients presenting...

Descripción completa

Detalles Bibliográficos
Autores principales: Farha, Mark W., Salami, Simpa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Current Best Practice for Prostate Biopsy: What is the evidence?
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201356/
https://www.ncbi.nlm.nih.gov/pubmed/35719272
http://dx.doi.org/10.1177/17562872221103988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201356/
https://www.ncbi.nlm.nih.gov/pubmed/35719272
http://dx.doi.org/10.1177/17562872221103988

Ejemplares similares